کمپنی

As industry leaders in applying functional genomics to improve medicine discovery & development, we welcome @GOVUK's Genome Implementation Plan. As genomics continues to revolutionise science, we can continue to help find better medicines, faster! gsk.to/3f0KKAT

“The best advice was from my Dad.” Sumitra, Vaccines, Singapore, tells us about unexpected journeys and why she’s proud of our industry’s response to Covid-19. She’s one of our #OutstandingPeople delivering world-class science & Innovation #ItsInOurGenes gsk.to/3fxIhN4

Tomorrow we bring together NGOs, government and policymakers @devex #WHA74 to discuss why investing in community health workers is so critical. Fiona Smith-Laittan, VP Global Health, will share how we've helped train 30,000 through our partnership with @savetheChildrenUK. twitter.com/devex/status/1…

#News for #investors and #media: Canadian biopharma @medicagoinc have announced positive interim Phase 2 results for the adjuvanted #COVID19 #vaccine candidate, which combines their innovative plant-based vaccine technology with our pandemic adjuvant. gsk.to/3eSqZeC

What’s next for real-world evidence? Real-world studies are already helping to shape the future of evidence-based medicine, generating important data on how our medicines benefit patients. #ATS2021 gsk.to/3ygw4VG

At GSK we have a 50-year legacy of delivering practice-changing breakthroughs in respiratory care. We’re proud to share our research at #ATS2021 as we continue to expand our knowledge of respiratory conditions and pursue innovative solutions for those struggling to breathe.

Today we’re marking #IDAHOBIT2021 and standing strong with our #LGBT colleagues in support of equality. At GSK, we’re committed to an inclusive workplace where all employees feel a sense of belonging and can be their authentic selves. 🌈 Learn more:gsk.to/2SRqMQdV9

Vaccines have already been helping protect people from diseases for well over 100 years, and at GSK we're exploring the potential of mRNA to create next-generation vaccines. Go #BehindTheScience to learn more 👇gsk.com/en-gb/behind-t…G

DYK As well as providing our adjuvant technology to several organisations working on promising #COVID19 vaccines, we’re collaborating with partners to find other ways to tackle the pandemic, including exploring potential therapeutic or treatment options: gsk.to/3onGWN9

#News for #investors and #media: Today, we’ve announced positive Phase 2 results for the adjuvanted #COVID19 vaccine candidate we’re co-developing with @sanofi. A Phase 3 study is expected to begin in the coming weeks. Learn more: gsk.to/3byWmsG